NF-κB and estrogen receptor α interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells

Journal of Cellular Biochemistry

Volumn 107, Issue 3, 2009, Pages 448-459

  Gionet, Nathalie ^a   Jansson, Deidre ^a   Mader, Sylvie ^b   Pratt, M A Christine ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Estrogen receptor; Hormone independence; NF B; Repression; Transactivation

Indexed keywords

ESTROGEN RECEPTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; SYNAPTOTAGMIN I; ESTROGEN RECEPTOR; HYBRID PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL COUNT; CELL STRAIN LCC1; CELL STRAIN MCF 7; CONTROLLED STUDY; EMBRYO; GENE REPRESSION; HORMONE RELEASE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; BINDING SITE; BREAST TUMOR; FEMALE; GENETIC TRANSFECTION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 66749103282     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22141     Document Type: Article

References (53)

1. Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato M, Sica V, Bresciani F, Weisz A. 1996. 17beta-estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 12:2315-2324.
2. Biswas DK, Dai S-C, Cruz A, Weiser B, Graner E, Pardee AB. 2001. The nuclear factor kappa B (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci USA 98:10386-10391. (Pubitemid 32803029)
3. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, Inglehart JD. 2004. NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101:10137-10142. (Pubitemid 38891208)
4. Brunner N, Boulay V, Fojo A, Freter CE, Lippman ME, Clarke R. 1993. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. Cancer Res 53:283-290. (Pubitemid 23031838)
5. Chen CL, Edelstein LC, Gelinas C. 2000. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20:2687-2695.
6. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. 1997. Suppression of tumor-necrosis factor-induced cell death by inhibitor of apoptosis cIAP2 is under NF-κB control. Proc Natl Acad Sci USA 94:10057-10062. (Pubitemid 27406993)
7. Clarke R, Brunner N, Katzenellenbogen BS, Thompson EW, Norman MJ, Koppi C, Paik S, Lippman ME, Dickson RB. 1989. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proc Natl Acad Sci USA 10:3649-3653. (Pubitemid 19141822)
8. Cogswell PC, Scheinman RI, Baldwin AS, Jr. 1993. Promoter of the human NF-κB p50/p105 gene. Regulation by NF-κB subunits and by c-REL. J Immunol 150:2794-2804.
9. Eng FC, Barsalou A, Akutsu N, Mercier I, Zechel C, Mader S, White JH. 1998. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain. J Biol Chem 273:28371-28377. (Pubitemid 28496140)
10. Evans MJ, Harris HA, Miller CP, Karathanasis SK, Adelman SJ. 2002. Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways. Endocrinology 143:3785-3795. (Pubitemid 35244357)
11. Fuqua SA. 2001. The role of estrogen receptors in breast cancer metastasis. J Mammary Gland Biol Neoplasia 6:407-417. (Pubitemid 39600498)
12. Fuqua SA, Cui Y. 2004. Estrogen and progesterone receptor isoforms: Clinical significance in breast cancer. Br Cancer Res Treat 87 (Suppl 1): S3-S10. (Pubitemid 40104685)
13. Galien R, Garcia T. 1997. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κB site. Nucleic Acids Res 25:2424-2429. (Pubitemid 27303703)
14. Ghisletti S, Meda C, Maggi A, Vegeto E. 2005. 17beta-estradiol inhibits inflammatory gene expression by controlling NF-κB intracellular localization. Mol Cell Biol 25:2957-2968. (Pubitemid 40464301)
15. Gilmore TD. 1999. The Rel/NF-kappa B signal transduction pathway: Introduction. Oncogene 49:6842-6844.
16. Graham ML, Krett NL, Miller LA, Leslie KK, Gordon DF, Wood WM, Wei LL, Horwitz KB. 1990. T47DCO cells, genetically unstable and containing estrogen receptor mutations are a model for the progression of breast cancers to hormone resistance. Cancer Res 50:6208-6217. (Pubitemid 20323676)
17. Han F, Miksicek R, Clarke R, Conrad SE. 2004. Expression of an estrogen receptor variant lacking exon 3 in derivatives of MCF-7 cells with acquired estrogen independent or tamoxifen resistance. J Mol Endocrinol 32:935-945. (Pubitemid 38877695)
18. Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, Rosen CA, Narayanan R. 1993. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci USA 90(21): 9901-9905. (Pubitemid 23328218)
19. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M. 1999. NF-κB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S phase transition. Mol Cell Biol 19:2690-2698. (Pubitemid 29144513)
20. Jeng MH, Jiang SY, Jordan VC. 1994. Paradoxical regulation of estrogen-dependent growth factor gene expression in estrogen receptor (ER)-negative human breast cancer cells stably expressing ER. Cancer Lett 82:123-128. (Pubitemid 24231975)
21. Jiang S-Y, Jordan VC. 1992. Growth regulation of estrogen receptor negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 84:580-591.
22. Johnston SR, Saccani-Jotti G, Smith IE, Salter J, Newby J, Coppen M, Ebbs SR, Dowsett M. 1995. Changes in estrogen receptor, progesterone receptor and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res 55:3331-3338.
23. Jordan VC. 2004. Selective estrogen receptor modulation: Concept and consequences in cancer. Cancer Cell 3:207-213. (Pubitemid 38402112)
24. Joyce D, Albanese C, Steer J, Fu M, Bouzahzah B, Pestell RG. 2001. NF-kappaB and cell cycle regulation: The cyclin connection. Cytokine Growth Factor Rev 12:73-90. (Pubitemid 32294588)
25. Karin M. 1999. How NF-kappa B is activated: The role of the Ikappa B kinase (IKK) complex. Oncogene 49:6867-6874.
26. Karin M, Cao Y, Greten FR, Li ZW. 2002. NF-kappa B in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2:301-310. (Pubitemid 37328783)
27. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y. 1987. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res 47:4355-4360. (Pubitemid 17128144)
28. Kitamura T, Sekimata M, Kikuchi S, Homma Y. 2005. Involvement of poly(ADP-ribose) polymerase I in ErbB2 expression in rheumatoid synovial cells. Am J Physiol (Cell Physiol) 289:C82-C88. (Pubitemid 40880827)
29. Klein-Hitpass L, Ryffel GU, Heitlinger E, Cato AC. 1988. A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucl Acids Res 16:647-663.
30. Lazennec G, Katzenellenbogen BS. 1999. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells. Mol Cell Endocrinol 149:93-105. (Pubitemid 29236228)
31. Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC. 2005. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst 97:1746-1759. (Pubitemid 41782284)
32. Liu H, Lee ES, Gajdos C, Pearce ST, Chen B, Osipo C, Loweth J, McKian K, DeLos Reyes A, Wing L, Jordan VC. 2003. Apoptotic action of 17-beta estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo. J Natl Cancer Inst 95:1586-1597. (Pubitemid 37455926)
33. Liu H, Liu K, Bodenner DL. 2005. Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor-κB transactivation. Cytokine 4:251-257. (Pubitemid 41097360)
34. Mader S, Chambon P, White JH. 1993. Defining a minimal estrogen receptor DNA binding domain. Nucleic Acid Res 21:1125-1132. (Pubitemid 23155606)
35. McGuire WL, Chamness GC, Fuqua SA. 1992. Abnormal estrogen receptor in clinical breast cancer. J Steroid Biochem Mol Biol 43:243-247.
36. McKay LI, Cidlowski JA. 1998. Cross-talk between nuclear factor-κB and the steroid hormone receptors: Mechanisms of mutual antagonism. Mol Endocrinol 12:45-56. (Pubitemid 28124778)
37. Montano MM, Katzenellenbogen BS. 1997. The quinone reductase gene: A unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci USA 94:2581-2586. (Pubitemid 27136918)
38. Murphy CS, Pink JJ, Jordan VC. 1990. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Cancer Res 50:7285-7292.
39. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Sledge GW, Jr. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629-3639.
40. Nettles KW, Gil G, Nowak J, Metivier R, Sharma VB, Greene GL. 2008. CBP is a dosage-dependent regulator of nuclear factor-κB suppression by the estrogen receptor. Mol Endocrinol 22:263-272.
41. Paya CV, Ten RM, Bessia C, Alcami J, Hay RT, Virelizier JL. 1992. NF-κB-dependent induction of the NF-κB p50 subunit gene promoter underlies its self-perpetuation of human immunodeficiency virus transcription in monocytic cells. Proc Natl Acad Sci USA 89:7826-7830.
42. Perillo B, Sasso A, Abbondanza C, Palumbo G. 2000. 17Beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20:2890-2901. (Pubitemid 30183508)
43. Pink JJ, Bilimoria MM, Assikis J, Jordan VC. 1996. Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation. Br J Cancer 74:1227-1236. (Pubitemid 26360111)
44. Pratt MAC, Bishop TE, White D, Yasvinski G, Menard M, Niu MY, Clarke R. 2003. Estrogen withdrawal-induced NF-κB activity and Bcl-3 expression in breast cancer cells: Roles in growth and hormone-independence. Mol Cell Biol 23:6887-6900. (Pubitemid 37220039)
45. Ray P, Ghosh SK, Zhang DH, Ray A. 1997. Repression of interleukin-6 gene expression by 17 beta-estradiol: Inhibition of the DNA binding activity of the transcription factors NF-IL6 and NF-κB by the estrogen receptor. FEBS Lett 409:79-85. (Pubitemid 27248571)
46. Sabbah M, Courilleau D, Mester J, Redeuilh G. 1999. Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element. Proc Natl Acad Sci USA 96:11217-11222. (Pubitemid 29487361)
47. Stein B, Yang MX. 1995. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBP beta. Mol Cell Biol 15:4971-4979.
48. Valentine JE, Kalkhoven E, White R, Hoare S, Parker MG. 2000. Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression. J Biol Chem 275:25322-25329. (Pubitemid 30658779)
49. Viatour P, Bentires-Alj M, Chariot A, Deregowski V, de Leval L, Merviall M-P, Bours V. 2003. NF-κB2/p100 induces Bcl-2 expression. Leukemia 17:1349-1356. (Pubitemid 36857343)
50. Wolf DM, Jordan VC. 1994. The estrogen receptor from a tamoxifen-stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain. Br Cancer Res Treat 1:129-138. (Pubitemid 24264219)
51. Zajchowski DA, Sager R, Webster L. 1993. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res 53:5004-5011. (Pubitemid 23326200)
52. Zheng X, Zhang Y, Chen YQ, Castranova V, Shi X, Chen F. 2005. Inhibition of NF-κB stabilizes gadd45alpha mRNA. Biochem Biophys Res Comm 329:95-99. (Pubitemid 40255425)
53. Zhou Y, Yau C, Gray JW, Chew K, Dairkee SH, Moore DH, Eppenberger U, Eppenberger-Castori S, Benz CC. 2007. Enhanced NF-κB and AP-1 transcriptional activity associated with antiestrogen resistance breast cancer. BMC Cancer 7 59. 10.1186/1471-2407-7-59. (Pubitemid 46614509)